Bee-derived propolis enhances antifungal drugs—but colonial extraction risks erode Indigenous stewardship of apitherapy
Original framing: “Bee-made propolis boosts an antifungal drug against yeast pathogens in lab tests” — Phys.org
Marginalized voices—such as small-scale beekeepers in Poland’s rural regions or Indigenous communities in Brazil’s Atlantic Forest—are absent from this narrative. These groups often oppose industrial propolis harvesting due to its environmental harm, including the disruption of native flora and the stress placed on bee colonies. For example, the *Xavante* people of Brazil have long used propolis in their healing rituals but face land encroachment by agribusinesses that now seek to exploit their traditional knowledge. The study’s framing silences these voices while centering corporate or academic interests.
This study exemplifies a broader pattern where Western science extracts and repurposes Indigenous and traditional knowledge for pharmaceutical gain, while obscuring its ecological and cultural roots.
The framing of propolis as a 'drug booster' ignores centuries of apicultural stewardship—from Māori *rongoā* to Slavic folk medicine—where bees and their products are treated as sacred, not commodified. Historical parallels, like the quinine colonialism of the 19th century, warn that unchecked extraction will repeat cycles of exploitation, this time targeting fungal pathogens in an era of antibiotic resistance. The solution lies not in scaling industrial propolis production, but in restoring Indigenous-led networks that integrate traditional knowledge with modern science—ensuring that bees, healers, and ecosystems are not collateral damage in the pursuit of medical breakthroughs. The trickster figure of **Eshu** might laugh at the irony: humanity seeks to 'enhance' nature’s medicines while destroying the very sources of their power.